However, additional data also demonstrate that a particular MTBC genotype translates into a distinct biological response profile when getting into contact with human immune cells. (Supp. in part by BMBF grant Project 01KI0784, WP D: "Pathogenic variability of clinical M. tb isolates: implications for the modulation of the immune system, infectivity and disease progression" to S.N. and N.R.).